Vivo Capital Fund VIII, L.P.'s Net Worth
Estimate Recalculated Sep 17, 2024 11:50PM EST
Who is Vivo Capital Fund VIII, L.P.
Vivo Capital Fund VIII, L.P. does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Crinetics Pharmaceuticals, Inc., Menlo Therapeutics Inc., Aligos Therapeutics, Inc., Terns Pharmaceuticals, Inc., IMPEL PHARMACEUTICALS INC, Bolt Biotherapeutics, Inc., Kadmon Holdings, Inc., and BioPharmX Corp.
SEC CIK
Vivo Capital Fund VIII, L.P.'s CIK is 0001618788
Past Insider Trading and Trends
No data available
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
